Group 1 - The core business of the company is the manufacturing of medical devices and consumables in the respiratory health field, including various types of sleep breathing machines and monitoring devices [2] - As of the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, with a year-on-year growth of 44.11% [2] - The company's gross profit margin stands at 49.57% [2] Group 2 - The company's current price-to-earnings (PE) ratio is 38.42, while the industry average PE ratio is 48.08, and the industry median is 36.05 [1][3] - The total market capitalization of the company is 6.816 billion yuan [1] - The company ranks 82nd in terms of PE ratio within its industry [1] Group 3 - The company holds a total of 633 domestic patents, including 107 invention patents and 390 utility model patents, as well as 202 international patents [2] - As of the first quarter of 2025, there are 14 institutions holding shares in the company, with a total of 26.9188 million shares and a market value of 2.172 billion yuan [1]
瑞迈特收盘下跌4.15%，滚动市盈率38.42倍，总市值68.16亿元
Sou Hu Cai Jing·2025-06-19 11:13